Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $54.4B |
| FY2017, ended Dec 31, 2017 | $56.4B |
| FY2018, ended Dec 31, 2018 | $46.0B |
| FY2019, ended Dec 31, 2019 | $36.9B |
| FY2020, ended Dec 31, 2020 | $16.1B |
| FY2021, ended Dec 31, 2021 | $27.1B |
| FY2022, ended Dec 31, 2022 | $56.7B |
| FY2023, ended Dec 31, 2023 | $52.5B |
| FY2024, ended Dec 31, 2024 | $46.4B |
| FY2025, ended Dec 31, 2025 | $40.6B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $48.6B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $10.1B |
| FY2017, ended Dec 31, 2017 | $12.5B |
| FY2018, ended Dec 31, 2018 | $17.8B |
| FY2019, ended Dec 31, 2019 | $20.9B |
| FY2020, ended Dec 31, 2020 | $17.8B |
| FY2021, ended Dec 31, 2021 | $26.0B |
| FY2022, ended Dec 31, 2022 | $36.6B |
| FY2023, ended Dec 31, 2023 | $23.2B |
| FY2024, ended Dec 31, 2024 | $22.7B |
| FY2025, ended Dec 31, 2025 | $21.6B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $23.9B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | −$574M | $667M |
| FY2017, ended Dec 31, 2017 | $1.31B | $1.26B |
| FY2018, ended Dec 31, 2018 | $4.13B | $2.69B |
| FY2019, ended Dec 31, 2019 | −$985M | $1.01B |
| FY2020, ended Dec 31, 2020 | −$14.8B | $1.42B |
| FY2021, ended Dec 31, 2021 | $2.32B | $7.56B |
| FY2022, ended Dec 31, 2022 | $13.3B | $12.3B |
| FY2023, ended Dec 31, 2023 | $4.70B | $6.61B |
| FY2024, ended Dec 31, 2024 | $2.36B | $5.18B |
| FY2025, ended Dec 31, 2025 | $1.61B | $4.11B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $6.54B | $4.79B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $2.23B |
| FY2017, ended Dec 31, 2017 | $1.67B |
| FY2018, ended Dec 31, 2018 | $3.03B |
| FY2019, ended Dec 31, 2019 | $3.03B |
| FY2020, ended Dec 31, 2020 | $2.01B |
| FY2021, ended Dec 31, 2021 | $2.76B |
| FY2022, ended Dec 31, 2022 | $984M |
| FY2023, ended Dec 31, 2023 | $1.43B |
| FY2024, ended Dec 31, 2024 | $2.13B |
| FY2025, ended Dec 31, 2025 | $1.97B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $4.15B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $9.80B |
| FY2017, ended Dec 31, 2017 | $9.90B |
| FY2018, ended Dec 31, 2018 | $10.4B |
| FY2019, ended Dec 31, 2019 | $38.6B |
| FY2020, ended Dec 31, 2020 | $35.8B |
| FY2021, ended Dec 31, 2021 | $29.0B |
| FY2022, ended Dec 31, 2022 | $19.1B |
| FY2023, ended Dec 31, 2023 | $19.0B |
| FY2024, ended Dec 31, 2024 | $25.3B |
| FY2025, ended Dec 31, 2025 | $21.4B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $12.8B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 30.8% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 764M |
| FY2017, ended Dec 31, 2017 | 765M |
| FY2018, ended Dec 31, 2018 | 750M |
| FY2019, ended Dec 31, 2019 | 895M |
| FY2020, ended Dec 31, 2020 | 932M |
| FY2021, ended Dec 31, 2021 | 934M |
| FY2022, ended Dec 31, 2022 | 900M |
| FY2023, ended Dec 31, 2023 | 879M |
| FY2024, ended Dec 31, 2024 | 939M |
| FY2025, ended Dec 31, 2025 | 986M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 1000M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash | Used in acquisitions |
|---|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $22.0M | $121M | $36.0M | — |
| FY2017, ended Dec 31, 2017 | $25.0M | $150M | $28.0M | — |
| FY2018, ended Dec 31, 2018 | $1.25B | $180M | $33.0M | — |
| FY2019, ended Dec 31, 2019 | $237M | $208M | $10.0B | — |
| FY2020, ended Dec 31, 2020 | $12.0M | $202M | $134M | — |
| FY2021, ended Dec 31, 2021 | $8.00M | $287M | $31.0M | — |
| FY2022, ended Dec 31, 2022 | $3.10B | $258M | $293M | — |
| FY2023, ended Dec 31, 2023 | $1.80B | $203M | $135M | — |
| FY2024, ended Dec 31, 2024 | $27.0M | $213M | $584M | $1.75B |
| FY2025, ended Dec 31, 2025 | $0 | $234M | $966M | — |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $117M | — | $330M | — |
Valuation
At current price- Market Cap
- $62.7B
- P/E
- 9.6×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 2.6×
- Price / Book
- 1.5×
- EV / EBITDA
- —. (Market cap + debt − cash) / EBITDA (TTM)
Growth
Trailing 12 months- Revenue (TTM)
- $23.9B
- Revenue Growth YoY
- 18.7%
- Revenue CAGR 3Y
- −16.2%
- Revenue CAGR 5Y
- 3.9%
- EPS Growth YoY
- 283%
- Net Income Growth YoY
- 288%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- —
- Net Margin
- 27.3%
- FCF Margin
- 20.0%
- Return on Equity
- 16.9%
Earnings
Trailing 12 months- Net Income
- $6.54B
- EPS (diluted)
- $6.47
- EBITDA
- —. Operating income + depreciation & amortization
- Operating Income
- —
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $4.15B
- Total Debt
- $12.8B
- Net Debt
- $8.65B
- Total Assets
- $80.4B
- Total Liabilities
- $38.0B
- Shareholders' Equity
- $41.7B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $11.0B
- Capital Expenditure
- $6.18B
- Free Cash Flow
- $4.79B
Dividends and risk
Last 12 months- Dividend Yield
- 1.7%
- Dividend / Share
- $1.04
- Beta (5Y)
- 0.25
Every ratio is calculated from the company’s reported figures.